The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125608568 12560856 8 F 201606 20160802 20160715 20160816 EXP GB-WATSON-2016-15439 ACTAVIS 69.00 YR F Y 0.00000 20160816 OT GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125608568 12560856 1 SS Dexamethasone (Unknown) DEXAMETHASONE 1 Intravenous (not otherwise specified) 8 MG, DAILY UNCONFIRMED 0 8 MG UNK QD
125608568 12560856 2 PS Epirubicin (Unknown) EPIRUBICIN 1 Intravenous (not otherwise specified) 126 MG, CYCLICAL, UNCONFIRMED 65445 126 MG UNK
125608568 12560856 3 SS Ondansetron (Unknown) ONDANSETRON 1 Intravenous (not otherwise specified) 8 MG, UNK UNCONFIRMED 0 8 MG UNK
125608568 12560856 4 SS Metoclopramide (Unknown) METOCLOPRAMIDE 1 Unknown UNK, DAILY, REDUCED DOSE UNCONFIRMED 0 UNK QD
125608568 12560856 5 SS EMEND APREPITANT 1 Oral 125 MG, DAILY 0 125 MG QD
125608568 12560856 6 SS NEULASTA PEGFILGRASTIM 1 Subcutaneous 6 MG, CYCLICAL, CYCLE 1/6, BY A PAXMAN SCALP COOLER 0 6 MG
125608568 12560856 7 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Intravenous (not otherwise specified) 0.9 MG, CYCLICAL 0 .9 MG
125608568 12560856 8 SS FLUOROURACIL. FLUOROURACIL 1 Intravenous (not otherwise specified) UNK UNK, CYCLICAL 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125608568 12560856 1 Product used for unknown indication
125608568 12560856 2 Breast cancer
125608568 12560856 3 Product used for unknown indication
125608568 12560856 4 Product used for unknown indication
125608568 12560856 5 Product used for unknown indication
125608568 12560856 6 Breast cancer
125608568 12560856 7 Product used for unknown indication
125608568 12560856 8 Breast cancer

Outcome of event

Event ID CASEID OUTC COD
125608568 12560856 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125608568 12560856 Alopecia
125608568 12560856 Body temperature abnormal
125608568 12560856 Condition aggravated
125608568 12560856 Cough
125608568 12560856 Diarrhoea
125608568 12560856 Dyspnoea
125608568 12560856 Ear pain
125608568 12560856 Eating disorder
125608568 12560856 Fatigue
125608568 12560856 Feeling abnormal
125608568 12560856 Glossodynia
125608568 12560856 Headache
125608568 12560856 Hypophagia
125608568 12560856 Intercepted drug administration error
125608568 12560856 Lethargy
125608568 12560856 Lower respiratory tract infection
125608568 12560856 Malaise
125608568 12560856 Nausea
125608568 12560856 Odynophagia
125608568 12560856 Oral pain
125608568 12560856 Oropharyngeal pain
125608568 12560856 Pharyngeal erythema
125608568 12560856 Productive cough
125608568 12560856 Sputum discoloured
125608568 12560856 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125608568 12560856 2 20160608 0
125608568 12560856 7 20160608 0
125608568 12560856 8 20160608 0